Gries Financial LLC Bristol Myers Squibb CO Transaction History

Gries Financial LLC

$535 Million
Q1 2024

A detailed history of Gries Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gries Financial LLC holds 68,117 shares of BMY stock, worth $2.7 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

68,117

Previous 41,779 63.04%

Holding current value

$2.7 Million

Previous $2.14 Million 72.33%

% of portfolio

0.69%

Previous 0.53%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $1.26 Million - $1.43 Million	26,338 Added 63.04%	68,117 $3.69 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $64,575 - $77,056	-1,332 Reduced 3.09%	41,779 $2.14 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $42,143 - $47,123	-728 Reduced 1.66%	43,111 $2.5 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $28,542 - $31,691	-448 Reduced 1.01%	43,839 $2.8 Million
Q1 2023 Jun 21, 2023	SELL	$65.71 - $74.53 $128,068 - $145,258	-1,949 Reduced 4.22%	44,287 $3.07 Million

Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $610,225 - $722,592	8,911 Added 23.87%	46,236 $3.33 Million
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $91 - $54,325	707 Added 1.93%	37,325 $2.65 Million
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $734,478 - $808,917	-10,114 Reduced 21.64%	36,618 $2.82 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $571,764 - $685,596	9,300 Added 24.85%	46,732 $3.41 Million
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $988,240 - $1.15 Million	18,427 Added 96.96%	37,432 $2.33 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $8,875 - $10,396	-150 Reduced 0.78%	19,005 $1.13 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.14 Million - $1.28 Million	19,155 New	19,155 $1.25 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.

Account

Gries Financial LLC Bristol Myers Squibb CO Transaction History